Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Multiple sclerosis in Finland 2018-Data from the national register.

Laakso SM, Viitala M, Kuusisto H, Sarasoja T, Hartikainen P, Atula S, Tienari PJ, Soilu-Hänninen M.

Acta Neurol Scand. 2019 Nov;140(5):303-311. doi: 10.1111/ane.13145. Epub 2019 Jul 29.

PMID:
31271648
2.

Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis.

Hänninen K, Viitala M, Paavilainen T, Karhu JO, Rinne J, Koikkalainen J, Lötjönen J, Soilu-Hänninen M.

Front Neurol. 2019 May 3;10:459. doi: 10.3389/fneur.2019.00459. eCollection 2019.

3.

Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors.

Viitala M, Virtakoivu R, Tadayon S, Rannikko J, Jalkanen S, Hollmén M.

Clin Cancer Res. 2019 Jun 1;25(11):3289-3303. doi: 10.1158/1078-0432.CCR-18-3016. Epub 2019 Feb 12.

PMID:
30755440
4.

Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice.

Dunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, Hollmén M, Jalkanen S, Salmi M.

Front Immunol. 2018 Oct 8;9:2257. doi: 10.3389/fimmu.2018.02257. eCollection 2018.

5.

How do different extracorporeal circulation systems affect metoprolol bioavailability in coronary artery bypass surgery patients.

Kokki H, Maaroos M, Ellam S, Halonen J, Ojanperä I, Ranta M, Ranta VP, Tolonen A, Lindberg O, Viitala M, Hartikainen J.

Eur J Clin Pharmacol. 2018 Jun;74(6):785-792. doi: 10.1007/s00228-018-2437-1. Epub 2018 Mar 9.

PMID:
29523917
6.

Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice.

Rinne P, Kadiri JJ, Velasco-Delgado M, Nuutinen S, Viitala M, Hollmén M, Rami M, Savontaus E, Steffens S.

Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):313-323. doi: 10.1161/ATVBAHA.117.310418. Epub 2017 Dec 28.

7.

High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.

Ketola K, Viitala M, Kohonen P, Fey V, Culig Z, Kallioniemi O, Iljin K.

J Mol Biochem. 2016 Mar 30;5(1):12-22.

8.

A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.

Gustafsson M, Gawel DR, Alfredsson L, Baranzini S, Björkander J, Blomgran R, Hellberg S, Eklund D, Ernerudh J, Kockum I, Konstantinell A, Lahesmaa R, Lentini A, Liljenström HR, Mattson L, Matussek A, Mellergård J, Mendez M, Olsson T, Pujana MA, Rasool O, Serra-Musach J, Stenmarker M, Tripathi S, Viitala M, Wang H, Zhang H, Nestor CE, Benson M.

Sci Transl Med. 2015 Nov 11;7(313):313ra178. doi: 10.1126/scitranslmed.aad2722.

9.

Association of Adiponectin with Adolescent Cardiovascular Health in a Dietary Intervention Study.

Jaakkola JM, Pahkala K, Viitala M, Rönnemaa T, Viikari J, Niinikoski H, Lagström H, Jula A, Simell O, Raitakari O.

J Pediatr. 2015 Aug;167(2):353-60.e1. doi: 10.1016/j.jpeds.2015.04.044. Epub 2015 May 15.

PMID:
25982143
10.

The L1TD1 protein interactome reveals the importance of post-transcriptional regulation in human pluripotency.

Emani MR, Närvä E, Stubb A, Chakroborty D, Viitala M, Rokka A, Rahkonen N, Moulder R, Denessiouk K, Trokovic R, Lund R, Elo LL, Lahesmaa R.

Stem Cell Reports. 2015 Mar 10;4(3):519-28. doi: 10.1016/j.stemcr.2015.01.014. Epub 2015 Feb 19.

11.

Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels.

Närvä E, Pursiheimo JP, Laiho A, Rahkonen N, Emani MR, Viitala M, Laurila K, Sahla R, Lund R, Lähdesmäki H, Jaakkola P, Lahesmaa R.

PLoS One. 2013 Nov 13;8(11):e78847. doi: 10.1371/journal.pone.0078847. eCollection 2013.

12.

High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.

Lehtinen L, Ketola K, Mäkelä R, Mpindi JP, Viitala M, Kallioniemi O, Iljin K.

Oncotarget. 2013 Jan;4(1):48-63.

Supplemental Content

Loading ...
Support Center